Why Add the Glucagon Receptor?

Semaglutide acts on one receptor (GLP-1). Tirzepatide acts on two (GIP + GLP-1). Retatrutide adds a third: the glucagon receptor (GCGR). Glucagon is classically known as a counter-regulatory hormone that raises blood glucose — the opposite of insulin. Adding glucagon receptor agonism to a metabolic drug seems counterintuitive, but at the doses used in combination, the glucagon receptor's effect on energy expenditure and hepatic fat oxidation dominates over its blood-glucose-raising effect, which is blunted by the simultaneous GLP-1-mediated insulin sensitization.

Triple Agonism: Mechanism Summary

Retatrutide's three-receptor strategy targets: GLP-1-R (appetite suppression, insulin secretion, slowed gastric emptying), GIP-R (improved insulin sensitivity, adipose tissue metabolism), GCGR (increased hepatic fat oxidation, elevated basal metabolic rate). The result is weight loss driven by both reduced intake AND increased expenditure — a combination that single or dual agonists do not fully achieve.

Phase 2 Results: 24.2% Body Weight Loss

The published Phase 2 trial (NEJM, 2023) evaluated retatrutide at multiple doses in adults with obesity. At the highest dose (12mg/week), participants lost a mean of 24.2% of body weight at 48 weeks. For context: semaglutide 2.4mg achieves ~15-17% at 68 weeks; tirzepatide 15mg achieves ~21% at 72 weeks. Retatrutide achieved its result at a shorter timepoint and higher magnitude. Phase 3 trials are ongoing as of 2024.

Research Documentation Standards

Retatrutide is a 39-amino acid peptide with a fatty acid modification (MW ~4,862 Da). As with tirzepatide, MS identity confirmation is required — the fatty acid side chain is structurally defining. HPLC purity targets are ≥98%. Because retatrutide is a newer compound than semaglutide or tirzepatide, researchers should be particularly diligent about documentation, as there is less established quality benchmark to compare against. ISO 17025 lab testing with batch-specific lot documentation is the minimum acceptable standard.